6-83921134-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016230.4(CYB5R4):c.617C>A(p.Ala206Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000216 in 1,530,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_016230.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYB5R4 | NM_016230.4 | c.617C>A | p.Ala206Glu | missense_variant | 8/16 | ENST00000369681.10 | NP_057314.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYB5R4 | ENST00000369681.10 | c.617C>A | p.Ala206Glu | missense_variant | 8/16 | 1 | NM_016230.4 | ENSP00000358695.3 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152094Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000132 AC: 3AN: 226772Hom.: 0 AF XY: 0.00000813 AC XY: 1AN XY: 123038
GnomAD4 exome AF: 0.0000203 AC: 28AN: 1378528Hom.: 0 Cov.: 27 AF XY: 0.0000233 AC XY: 16AN XY: 685304
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152094Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74294
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 11, 2024 | The c.617C>A (p.A206E) alteration is located in exon 8 (coding exon 8) of the CYB5R4 gene. This alteration results from a C to A substitution at nucleotide position 617, causing the alanine (A) at amino acid position 206 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at